DEA Cancels Proposed Ban Of Five Psychedelics, Giving Scientists More Time To Research Therapeutic Benefits

DEA Cancels Proposed Ban Of Five Psychedelics, Giving Scientists More Time To Research Therapeutic Benefits
MJ moment

The Drug Enforcement Administration (DEA) has withdrawn a controversial proposal to ban five psychedelic compounds—a decision that’s being celebrated by advocates and researchers. Just weeks after posting a notice of a rare hearing that was scheduled in the face of broad pushback against the proposed prohibition, DEA said on Friday that it was no longer necessary because it is pulling back the idea to enact the ban, at least for now, and has instead decided to submit a request for an updated scientific review of the tryptamines from the U.S. Department of Health and Human Services (HHS). DEA first proposed scheduling the compounds—4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET and DiPT—in January. And it faced significant criticism, receiving nearly 600 messages during a public comment period, with most opposing the rule change and requesting a hearing. The agency’s own administrative court subsequently agreed that there was a need to hold a hearing on the matter before the prohibition could be enacted. But while it seemed that the stage was set for an August 22 hearing, DEA ultimately decided against it, which is at least a short-term victory for researchers who say the designating the tryptamines as Schedule I, as proposed, would seriously inhibit studies into their therapeutic potential. 5 psychedelic tryptamines, kept off schedule I? DEA scheduling proceedings—terminated: “DEA is withdrawing the proposed rule…canceling the public hearing & terminating the pending hearing proceedings” Unprecedented outcome—a result of extraordinary lawyering by Matt Zorn 1/2 https://t.co/ZfBq8OJurB pic.twitter.com/OJHjhcDNil — Graham Pechenik (@calyxlaw) July 22, 2022 It’s not clear how long it will take HHS to conduct a new scientific review of the substances. And it’s also not guaranteed that it will recommend keeping the compounds unscheduled or placing them in a less restrictive schedule. But the hearing cancellation means that, at the very least, scientists will have more…

Excerpt only …
READ MORE BELOW
Source : DEA Cancels Proposed Ban Of Five Psychedelics, Giving Scientists More Time To Research Therapeutic Benefits

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.